Clinical Trials at UNC Health Cancer Care Garner
As of July 2026, 3 paid clinical trials are recruiting at UNC Health Cancer Care Garner in Garner, North Carolina. Active studies at this site cover conditions such as Dry Eye Disease (DED), Anatomic Stage II Breast Cancer AJCC v8 and Anatomic Stage III Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
3 clinical trials at UNC Health Cancer Care Garner
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Common conditions studied in Garner
- Dry Eye Disease (DED) (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage III Breast Cancer AJCC v8 (1 active study)
- Breast Cancer (1 active study)
- HER2-Negative Breast Carcinoma (1 active study)
- Hormone Receptor-Positive Breast Carcinoma (1 active study)
Leading research sponsors in Garner
- NRG Oncology
- Dompé Farmaceutici S.p.A
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- Oculis
Frequently asked questions
How many paid clinical trials are currently recruiting in Garner?
There are approximately 6 recruiting clinical trials in Garner, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Garner pay participants?
Most recruiting trials in Garner compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Garner?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Garner?
The most common conditions under active study in Garner include Dry Eye Disease (DED) (2), Anatomic Stage II Breast Cancer AJCC v8 (1), Anatomic Stage III Breast Cancer AJCC v8 (1), Breast Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Garner?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Garner on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Garner?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Garner?
Recruiting research sites in Garner include UNC Health Cancer Care Garner, Oculus Research, Inc., Rex Hematology Oncology Associates - Garner, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Garner right now?
The largest active categories in Garner are Cancer & tumors (3), Eye & vision (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.